Financhill
Sell
46

TGTX Quote, Financials, Valuation and Earnings

Last price:
$28.88
Seasonality move :
26.56%
Day range:
$27.71 - $28.96
52-week range:
$12.84 - $36.84
Dividend yield:
0%
P/E ratio:
39.15x
P/S ratio:
16.97x
P/B ratio:
23.40x
Volume:
2.8M
Avg. volume:
2.1M
1-year change:
62.52%
Market cap:
$4.5B
Revenue:
$233.7M
EPS (TTM):
-$0.11

Earnings Data

Next earnings date for TGTX
Feb 28
2025
Most recent earnings per share
$0.02
Missed by $0.01
(Nov 4/2024)
Consensus Estimate
$0.03
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TGTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $113.3M -- -- $0.14 --
02/28/2025 Q4 $98.3M -- -- $0.08 --
11/04/2024 Q3 $81.7M $83.9M $0.02 $0.03 -$0.01
08/06/2024 Q2 $65.9M $73.5M $0.04 -$0.04 $0.08
05/01/2024 Q1 $54.6M $63.5M -$0.07 -$0.05 -$0.03
02/28/2024 Q4 $40.1M $44M -$0.10 -$0.11 $0.01
11/01/2023 Q3 -- -- $0.73 $0.10 $0.63
08/01/2023 Q2 -- -- -$0.34 -$0.25 -$0.09
05/01/2023 Q1 -- -- -$0.28 -$0.34 $0.06
02/28/2023 Q4 -- -- -$0.39 -$0.26 -$0.13
11/10/2022 Q3 -- -- -$0.26 -$0.38 $0.12
08/08/2022 Q2 -- -- -$0.30 -$0.57 $0.27
05/10/2022 Q1 -- -- -$0.51 -$0.63 $0.12
03/01/2022 Q4 -- -- -$0.70 -$0.68 -$0.02
11/04/2021 Q3 -- -- -$0.65 -$0.57 -$0.08
08/02/2021 Q2 -- -- -$0.59 -$0.50 -$0.09
05/10/2021 Q1 -- -- -$0.69 -$0.50 -$0.19
03/02/2021 Q4 -- -- -$0.71 -$0.61 -$0.10
11/09/2020 Q3 -- -- -$0.73 -$0.44 -$0.29
08/10/2020 Q2 -- -- -$0.47 -$0.33 -$0.14
05/11/2020 Q1 -- -- -$0.48 -$0.38 -$0.11
03/03/2020 Q4 -- -- -$0.44 -$0.50 $0.06
11/12/2019 Q3 -- -- -$0.69 -$0.36 -$0.34
08/09/2019 Q2 -- -- -$0.42 -$0.42 --
05/10/2019 Q1 -- -- -$0.43 -$0.44 $0.01
03/01/2019 Q4 -- -- -$0.69 -$0.43 -$0.27
11/09/2018 Q3 -- -- -$0.43 -$0.50 $0.07
08/07/2018 Q2 -- -- -$0.59 -- --
05/08/2018 Q1 -- -- -$0.59 -- --
03/08/2018 Q4 -- -- -$0.46 -- --
11/08/2017 Q3 -- -- -$0.48 -- --
08/09/2017 Q2 -- -- -$0.45 -- --
05/05/2017 Q1 -- -- -$0.52 -- --
03/10/2017 Q4 -- -- -$0.48 -- --
11/07/2016 Q3 -- -- -$0.50 -- --
08/08/2016 Q2 -- -- -$0.33 -- --
05/10/2016 Q1 -- -- -$0.28 -- --
03/07/2016 Q4 -- -- -$0.37 -- --
11/09/2015 Q3 -- -- -$0.28 -- --
08/10/2015 Q2 -- -- -$0.38 -- --
05/05/2015 Q1 -- -- -$0.35 -- --

TG Therapeutics Earnings Questions

  • How Much did TG Therapeutics Generate in Revenue Last Quarter?

    TG Therapeutics reported $83.9M worth of top line sales in its most recent quarter.

  • Did TG Therapeutics Beat Earnings Last Quarter?

    TG Therapeutics announced earnings per share of $0.02 which represents a miss of analyst forecast a $0.03 per share.

  • Is TG Therapeutics Profitable?

    TG Therapeutics reported $74.5M that represents $0.46 per share over the last quarter.

  • What is the Analyst Consensus for TG Therapeutics EPS Next Year?

    TG Therapeutics's earnings are forecast to grow from $0.09 per share to $0.16 per share next year representing an increase of 123.82%.

  • When is TG Therapeutics's Earnings Date?

    TG Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock